Skip to Main Content

Beth Anne Jones, PhD, MPH

Research Scientist in and Lecturer in Epidemiology (Chronic Diseases); Inaugural Director, Cancer Screening & Prevention Program

Contact Information

Beth Anne Jones, PhD, MPH

Office Location

Mailing Address

  • Chronic Disease Epidemiology

    Center for Cancer Prevention Research, 1 Church Street

    New Haven, CT 06510

    United States



Dr. Jones is a Yale-trained cancer epidemiologist whose work and teaching focus is on health disparities. Her research is primarily focused on racial/ethnic differences in cancer screening, prevention, and cancer outcomes. A recently completed study tested 4 evidence-based interventions to address overdue colorectal cancer screening in a large urban primary care clinic. Ongoing projects include working with Implementation Science research teams to address system and patient level factors that compromise the full benefit of cervical cancer screening in minority populations and in developing mitigation strategies to protect respiratory health in large clinical workplace. Other projects focus on the impact of COVID-19 on adults and GEN-Z populations in at-risk communities with implications for cancer prevention and screening behaviors.

In leadership roles in Community Outreach Education efforts for the Yale Comprehensive Cancer Center and as inaugural Director of Smilow Cancer Hospital's Cancer Screening & Prevention Program, Dr. Jones has led a number of programmatic efforts to engage underserved communities in cancer prevention and screening activities throughout a large catchment area. Using best community practices, adapted due to recent pandemic, we created a platform for reaching nearly 100,000 community members per year with vetted, evidence-based health prevention and screening messages in Spanish and English languages, launched a community facing navigation program that screened and addressed social determinants of health (SDOH) barriers, and are now adapting some of these strategies to engage traditionally under-served populations on the important role of cancer related genetic testing in a large health system.

These translational efforts are a natural outgrowth of her population-based studies of mammography screening and other health behaviors, breast density, and colorectal cancer screening in Hispanic/Latinas and African American/Black women living in the Northeast, US. Using a multidisciplinary approach, she has also evaluated the role(s) of obesity, tumor characteristics, selected genetic alterations and genetic polymorphisms, as well as social class, medical care, and psychosocial factors, in explaining differences cancer stage at diagnosis and survival between African Americans and Whites in breast, prostate, and colorectal cancer.

Education & Training

  • PhD
    Yale University, Epidemiology (1993)
  • MPH
    Yale School of Public Health, Epi / Health Services

Honors & Recognition

AwardAwarding OrganizationDate
Invited Testimony, The President’s Cancer Panel, America’s Demographic and Cultural Transformation: Implications for Cancer. Los Angeles, CA, Oct, 2009 HHS, NIH, NCI. President’s Cancer Panel Annual Report 2009-2010 (2011) 2009
Member, Board of DirectorsCommunity Health Action, Innovation and Networking, Inc. (CHAIN)2008
Co-Chair, Health Disparities Committee, CT Cancer Partnership2006
Co-Director, Office of the Elimination of Cancer Disparities, Yale Comprehensive Cancer Center2006
State of Connecticut Yale Comprehensive Cancer Center Breast Cancer Research Award2004
American Cancer Society Travel Award2002

Professional Service

President's Council on CancerPresenter/Speaker2009 - Present
CT Multicultural Health Partnership, State of CT Dept of Public HealthMember2008 - Present
Office of the Elimination of Cancer Disparities, Yale Comprehensive Cancer CenterDirector2006 - 2008
Health Disparities Committee, CT Cancer PartnershipChairperson2006 - 2008

Departments & Organizations